Effect of polymerization cycles on gloss, roughness, hardness and impact strength of acrylic resins

The aim of this study was to evaluate the conventional and boiled polymerization cycles on gloss, roughness, hardness and impact strength of acrylic resins. Samples were made for each Classico and QC-20 materials (n=10) in dental stone molds obtained from rectangular metallic matrices embedded in metallic flasks. The powder-liquid ratio and manipulation of the acrylic resins' were accomplished according to manufacturers' instructions and the resins were conventionally packed in metallic flasks. After polymerization by (1) conventional: 74 °C for 9 h (Classico) and (2) boiled: 20 min (QC-20) cycles, the samples were deflasked after cooling at room temperature and conventionally finished and polished. The properties were evaluated after storage in water at 37 °C for 24 h. Gloss was verified with Multi Gloss 268 meter (Konica Minolta), surface roughness was measured with Surfcorder SE 1700 rugosimeter (Kosaka), Knoop hardness number was obtained with HMV-200 microdurometer, and impact strength was measured in an Otto Wolpert-Werke device by Charpy system (40 kpcm). Data were subjected to Student's t-test (at α=0.05). The results were: Gloss: 67.7 and 62.2 for Classico and QC-20 resins, respectively; Surface roughness: 0.874 and 1.469 Ra-µm for Classico and QC-20, respectively; Knoop hardness: 27.4 and 26.9 for Classico and QC-20, respectively; and Impact strength: 37.6 and 33.6 kgf/cm2 for Classico and QC-20, respectively. No statistically significant difference (p>0.05)were found between the resins for the evaluated properties. In conclusion, conventional and boiled polymerization cycles had similar effects on gloss, roughness, hardness and impact strength of both Classico and QC-20 resins272176180CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQSem informaçãoO propósito neste estudo foi avaliar os ciclos de polimerização convencional e por fervura sobre o brilho, rugosidade, dureza e resistência ao impacto de resinas acrílicas. Amostras foram confeccionadas para cada resina Clássico ou QC-20 (n=20) em moldes de gesso obtidos de matrizes metálicas retangulares incluídas em muflas metálicas. A proporção monômero/polímero das resinas e manipulação foram de acordo com as recomendações dos fabricantes e a massa convencionalmente incluída em muflas metálicas. Após polimerização nos ciclos (1) convencional: 74 °C por 9 horas (Clássico) e (2) fervura: 20 min (QC-20), as amostras foram demufladas após esfriadas em temperatura ambiente e convencionalmente acabadas e polidas. As propriedades foram avaliadas após armazenagem das amostras em água a 37 °C por 24 h. O brilho foi verificado com medidor Multi Gloss 268 (Konica Minolta), a rugosidade avaliada com rugosímetro Surfcorder SE 1700 (Kosaka), a dureza Knoop foi obtida com microdurômetro HMV-200 (Shimadzu) e a resistência ao impacto determinada pelo sistema Charpy (Otto Wolpert Werke). Os dados submetidos ao teste t de Student (α=0.05) mostraram que Os resultados foram: brilho: 67,7 e 62,2 para Clássico e QC-20, respectivamente; rugosidade: 0,874 e 1,469 Ra-µm para Clássico e QC-20, respectivamente; dureza: 27,4 e 26,9 para Clássico e QC-20, respectivamente; e resistência ao impacto: 37,6 e 33,6 kgf/cm2 para Clássico e QC-20, respectivamente. Não houve diference estatisticamente significante entre as resinas para as propriedades avaliadas. Conclui-se que os ciclos de polimerização convencional e por fervura promoveram similares efeitos sobre o brilho, rugosidade, dureza e resistência ao impacto para ambas as resinas Clássico e QC-2

Polymerization cycles on hardness and surface gloss of denture bases

The aim of this study was to evaluate different polymerization cycles on the hardness and surface gloss of acrylic resins for denture bases. Classico and Vip Cril Plus acrylic resins samples were made in dental stone molds. Powder-liquid ratio and resin manipulation were according to the manufacturers’ instructions, and the resulting mass pressed in metallic fl asks. The polymerization cycles were A - hot water bath at 74°C for 9 hours; B - hot water bath at 74°C for 8 hours + 100°C for 1 hour, and C - hot water bath at 74°C for 2 hours + 100°C for 1 hour. After polymerization, the samples were defl asked and submitted to finishing and polishing procedures, and stored in water at 37°C for 24 hours. A hardness indenter with load of 25 gf for 10 s evaluated the Knoop hardness values. A gloss meter evaluated the surface gloss using a light incidence of 60°. Data were submitted to ANOVA and Tukey’s test (α = 0.05). Hardness: There were signifi cant differences between resins regardless of polymerization cycles (Classico = 22.28 and Vip Cril Plus = 25.83). Significant differences occurred among polymerization cycles regardless of resins (A = 25.83, B = 24.64 and C = 21.73). There was similarity for the resin and cycle interaction (Classico: A = 24.51, B = 22.68 and C = 19.65; Vip Cril Plus: A = 27.15, B = 26.53 and C = 23.81). Surface gloss. Significant differences were shown between resins regardless of polymerization cycle (Classico = 57.26 and Vip Cril Plus = 49.38) and between polymerization cycles regardless of resin (A = 48.82, B = 53.46 and C = 57.68). Statistical diff erences were also found for the resin and cycle interaction (Classico: A = 52.32, B = 63.79 and C = 55.67; Vip Cril Plus: A = 45.32, B = 43.14 and C = 59.69). Diff erent polymerization cycles showed similar eff ects on hardness and different effects on the surface gloss of denture base acrylic resins

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma a

The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

AIM: The SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery. METHODS: This was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4 weeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin. RESULTS: Overall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4 weeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, P = 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, P < 0.001). After adjustment, delay was not associated with a lower rate of complete resection (OR 1.18, 95% CI 0.90-1.55, P = 0.224), which was consistent in elective patients only (OR 0.94, 95% CI 0.69-1.27, P = 0.672). Longer delays were not associated with poorer outcomes. CONCLUSION: One in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the diseas

Delaying surgery for patients with a previous SARS-CoV-2 infection

Not availabl